Diagnostic performance and safety of NMK36 (trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid)-PET/CT in primary prostate cancer: multicenter Phase IIb clinical trial.-论文-万方医学网

第一作者： Hiroyoshi,Suzuki

第一单位： Department of Urology, Toho University Sakura Medical Center, Sakura hiroyoshi.suzuki@med.toho-u.ac.jp.

作者： Hiroyoshi,Suzuki ^[1] ; Yusuke,Inoue ^[2] ; Hiroyuki,Fujimoto ^[3] ; Junji,Yonese ^[4] ; Kazunari,Tanabe ^[5] ; Satoshi,Fukasawa ^[6] ; Tomio,Inoue ^[7] ; Shiro,Saito ^[8] ; Munehisa,Ueno ^[9] ; Akiharu,Otaka ^[10]

作者单位： Department of Urology, Toho University Sakura Medical Center, Sakura hiroyoshi.suzuki@med.toho-u.ac.jp. ^[1] Department of Diagnostic Radiology, Kitasato University School of Medicine, Sagamihara. ^[2] Department of Urology, National Cancer Center Hospital, Tokyo. ^[3] Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo. ^[4] Department of Urology, Tokyo Women's Medical University, Tokyo. ^[5] Prostate Center and Division of Urology, Chiba Cancer Center, Chiba. ^[6] Department of Radiology, Yokohama City University Graduate School of Medicine, Yokohama. ^[7] Department of Urology, National Hospital Organization Tokyo Medical Center, Tokyo. ^[8] Department of Uro-Oncology, Saitama Medical University International Medical Center, Hidaka. ^[9] Clinical Development Department, Nihon Medi-Physics Co., Ltd., Tokyo, Japan. ^[10]

主题词老年人(Aged);氨基酸类(Amino Acids);抗肿瘤药, 激素(Antineoplastic Agents, Hormonal);骨肿瘤(Bone Neoplasms);羧酸类(Carboxylic Acids);造影剂(Contrast Media);环丁烷类(Cyclobutanes);人类(Humans);淋巴结(Lymph Nodes);淋巴转移(Lymphatic Metastasis);男(雄)性(Male);中年人(Middle Aged);正电子发射断层显像术(Positron-Emission Tomography);试验预期值(Predictive Value of Tests);前列腺特异抗原(Prostate-Specific Antigen);前列腺切除术(Prostatectomy);前列腺肿瘤(Prostatic Neoplasms);放射性药物(Radiopharmaceuticals);安全(Safety);敏感性与特异性(Sensitivity and Specificity);体层摄影术, X线计算机(Tomography, X-Ray Computed)

DOI 10.1093/jjco/hyv181

PMID 26732384

发布时间 2018-12-02

检索历史清除

Diagnostic performance and safety of NMK36 (trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid)-PET/CT in primary prostate cancer: multicenter Phase IIb clinical trial.

Japanese journal of clinical oncology

相似文献

Japanese journal of clinical oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Diagnostic performance and safety of NMK36 (trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid)-PET/CT in primary prostate cancer: multicenter Phase IIb clinical trial.

Japanese journal of clinical oncology

相似文献

Japanese journal of clinical oncology

相关期刊

检索历史清除